Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
5.08
+0.34 (7.17%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Orchestra BioMed Holdings Employees
Orchestra BioMed Holdings had 86 employees as of December 31, 2025. The number of employees increased by 16 or 22.86% compared to the previous year.
Employees
86
Change (1Y)
16
Growth (1Y)
22.86%
Revenue / Employee
$371,814
Profits / Employee
-$692,698
Market Cap
305.33M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 86 | 16 | 22.86% |
| Dec 31, 2024 | 70 | 14 | 25.00% |
| Dec 31, 2023 | 56 | 11 | 24.44% |
| Sep 30, 2022 | 45 | - | - |
| Jun 30, 2022 | 42 | - | - |
| Mar 31, 2022 | 42 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| ProQR Therapeutics | 187 |
| Fate Therapeutics | 161 |
| Foghorn Therapeutics | 106 |
| Sionna Therapeutics | 59 |
| Immuneering | 57 |
| Pyxis Oncology | 56 |
| Vicore Pharma Holding AB | 46 |
OBIO News
- 4 days ago - Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 10 days ago - Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 17 days ago - Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference - GlobeNewsWire
- 26 days ago - Orchestra BioMed price target raised to $10 from $9 at Piper Sandler - TheFly
- 27 days ago - Orchestra BioMed reports Q2 EPS (37c), consensus (38c) - TheFly
- 27 days ago - Orchestra BioMed Holdings Quarterly report: Q2 2026 - Filings
- 27 days ago - Orchestra BioMed Holdings Earnings release: Q2 2026 - Filings
- 2 months ago - Orchestra BioMed joins Russell 3000, Russell 2000 Indexes - TheFly